Study paves way for revolutionizing the management of muscle disorders

The type 1 ryanodine receptor (RyR1) is an important calcium release channel in skeletal muscles essential for muscle contraction.

InComm Payments Acquires AI-Powered HSA Solution Zenda

What You Should Know: InComm Payments announced it has acquired Zenda, an AI-powered HSA and FSA solution. With aligned organizational goals of “helping more people

August 8, 2023

Glenmark agrees to market BeiGene’s oncology medicines in India

Tislelizumab and Zanubrutinib are the oncology medicines of BeiGene, which will be commercialised by Glenmark in India. Credit: T. Schneider / Shutterstock.com. Glenmark Pharmaceuticals subsidiary

May 21, 2024

Eckert & Ziegler to Supply Ablaze Pharmaceuticals with Lutetium-177 for Clinical Trials – Biotech Investments

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Contract Eckert & Ziegler to Supply Ablaze Pharmaceuticals with Lutetium-177 for Clinical Trials 23.10.2023

October 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.